Cargando…

P-4 Evaluating therapy outcome in Mysthenia Gravis

Detalles Bibliográficos
Autores principales:	Bisciglia, M., Albertini, M.E., Martignago, S., Ermani, M., Pegoraro, E., Angelini, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SpA 2011
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235869/

Ejemplares similares

P-1 Prognostic factors and course of myasthenia gravis
por: Albertini, E., et al.
Publicado: (2011)

New treatments for myasthenia: a focus on antisense oligonucleotides
por: Angelini, Corrado, et al.
Publicado: (2013)

Outcome measures and treatment effectiveness in late onset myasthenia gravis
por: Pasqualin, Francesca, et al.
Publicado: (2020)

Development and validation of the Myasthenia Gravis TeleScore (MGTS)
por: Pasqualin, F., et al.
Publicado: (2022)

Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII)
por: Pasqualin, Francesca, et al.
Publicado: (2021)

P-2 Two sisters with muscle lipid storage and carnitine deficiency in muscle and plasma
por: Angelini, C., et al.
Publicado: (2011)

MyastheniaGravis(MG) in a patient with Juvenile Idiopathic Arthritis
por: Scott, Christiaan, et al.
Publicado: (2011)

Evaluation of muscle biopsy in late-onset GSDII patients before and after enzyme replacement therapy (ERT)
por: Violano, R, et al.
Publicado: (2013)

Does only thymectomy influence on results of surgical treatment at patients with myasthenia gravis?
por: Pushkin, S, et al.
Publicado: (2013)

Subtotal thymectomy concomitant with emergency coronary revascularization in a myasthenia gravis case with severe left main stem stenosis
por: Yetkin, U, et al.
Publicado: (2013)

P18-03. Dendritic cell-based immune therapy against HIV-1
por: Gruters, RA, et al.
Publicado: (2009)

P02.144. Evaluation of health outcomes for members of a managed care organization referred for acupuncture
por: Sommers, E, et al.
Publicado: (2012)

P231: Risk factors for Acinetobacter baumannii colonization and infection among patients admitted to intensive care units
por: Giannella, M, et al.
Publicado: (2013)

P05.19. Outcomes in breast cancer treatment decision-making
por: McKenzie, E, et al.
Publicado: (2012)

Factors impact on insufficient nutrition and effects of timely adequate nutrition support on patient outcomes in adult intensive care patients
por: Savran, Y, et al.
Publicado: (2015)

P18-14 LB. Vacc-4x HIV p24-like peptide vaccine-associated increase of CD4 T-cells in chronically infected HIV-1 patients on antiretroviral therapy
por: Bengtsson, P, et al.
Publicado: (2009)

Oral manifestation of Goltz-Gorlin syndrome in a young girl
por: Callea, M, et al.
Publicado: (2012)

Modulation of HIV-1 replication in primary dendritic cells in contact with autologous CD4 T-lymphocytes
por: Su, B, et al.
Publicado: (2012)

Indications for marker clip in the setting of neoadjuvant/neoendocrine therapy
por: Fletcher, ME, et al.
Publicado: (2012)

Bioelectrical impedance vector analysis (BIVA) to evaluate seasonal variations in body composition of elite soccer players
por: Bonuccelli, Angelini, et al.
Publicado: (2011)

P02.126. Addition of chiropractic manipulative therapy to standard medical care may improve outcomes for acute low back pain in active-duty military personnel
por: Goertz, C, et al.
Publicado: (2012)

P-9 Construction of a database for a nation-wide Italian collaborative network of mitochondrial diseases
por: Mancuso, M., et al.
Publicado: (2011)

Aneurysmal subarachnoid hemorrhage: factors associated with worse functional outcome
por: Sánchez Montori, L, et al.
Publicado: (2015)

Evaluation of outcome in critically ill patients with Acinetobacter baumannii bacteremia
por: Pratikaki, M, et al.
Publicado: (2005)

Serum lactic acid in the evaluation of outcome in the ICU
por: Khalaf, A, et al.
Publicado: (2009)

Atypical onset as predictor of poor outcome in Pediatric Systemic Lupus Erythematosus (pSLE)
por: Taddio, A, et al.
Publicado: (2008)

P19-12. Multimers of llama heavy chain variable domains that bind to the 2F5/4E10 epitope neutralize HIV-1
por: Liu, Y, et al.
Publicado: (2009)

P-081: EVALUATION OF THE SEXUALITY OF ADULT HOMOZYGOUS SICKLE CELL PATIENTS WITH A HISTORY OF PRIAPISM IN SENEGAL
por: M., SECK, et al.
Publicado: (2022)

Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4-cell decline
por: de Jong, E, et al.
Publicado: (2010)

Interim results of the SHARF4 study: outcome of acute renal failure with different treatment modalities
por: Malbrain, M, et al.
Publicado: (2004)

P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults
por: Enama, ME, et al.
Publicado: (2009)

Outcome of patients treated with renal replacement therapy for acute kidney injury
por: Desegher, A, et al.
Publicado: (2006)

5613191 KNOWLEDGE, ATTITUDE, PRACTICE OF GENOTYPE SCREENING AMONG UNDERGRADUATES MEDICAL STUDENTS IN THE UNIVERSITY OF ABUJA
por: Cegbeyi, M.E., et al.
Publicado: (2023)

Evaluation of microcirculation before and during continuous renal replacement therapy and the impact of dose prescription
por: Pipili, C, et al.
Publicado: (2012)

P-041: DEATH ASSOCIATED WITH DELTA VARIANT COVID-19 AMONG SICKLE CELL DISEASE ADULT PATIENTS DURING THE 2021 4TH WAVE IN GUADELOUPE
por: E., BERNIT, et al.
Publicado: (2022)

P239: Salmonella group B 4,5 outbreak on a neonatology unit
por: Grande, M, et al.
Publicado: (2013)

O-5 Novel HLA II associations in myasthenia gravis
por: Massa, R., et al.
Publicado: (2011)

P16-15. Epitope mapping of HIV-specific CD8+ T-cells responses by polyfunctional and proliferation responses reveal distinct specificity defined by function
por: Richmond, ME, et al.
Publicado: (2009)

P55. Dendritic cell vaccination for postremission therapy in AML
por: Lichtenegger, FS, et al.
Publicado: (2014)

P04.40. Lifestyle therapy use in pediatric cancer survivors
por: Karlik, J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_89isr800fsfmqkov4htv83lmvg